Edition:
United Kingdom

Humanwell Healthcare Group Co Ltd (600079.SS)

600079.SS on Shanghai Stock Exchange

17.88CNY
15 Dec 2017
Change (% chg)

¥-0.30 (-1.65%)
Prev Close
¥18.18
Open
¥18.20
Day's High
¥18.20
Day's Low
¥17.60
Volume
7,228,049
Avg. Vol
10,849,825
52-wk High
¥21.50
52-wk Low
¥17.31

Latest Key Developments (Source: Significant Developments)

Humanwell Healthcare Group completes investment in unit RFSW Investment Pte Ltd
Friday, 15 Dec 2017 

Dec 15 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS> ::Says it invested 805.4 million yuan in wholly owned Singapore unit RFSW Investment Pte. Ltd.Jissbon, a Wuhan-based commodities company, becomes controlling subsidiary of RFSW Investment Pte. Ltd after equity investment .  Full Article

Humanwell Healthcare Group unit gets approval of clinical trial for Meisuoshuli tablets
Wednesday, 6 Dec 2017 

Dec 6 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS> ::Says its Wuhan-based unit gets approval of clinical trial for Meisuoshuli tablets, which is used for anti-inflammatory, analgesic and antipyretic .  Full Article

Humanwell Healthcare's shareholder bought shares worth 143.7 mln yuan during Jun 28-Nov 29
Wednesday, 29 Nov 2017 

Nov 29 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS>::SAYS CONTROLLING SHAREHOLDER HAS BOUGHT 143.7 MILLION YUAN ($21.78 million) WORTH OF COMPANY SHARES BETWEEN JUNE 28 AND NOV 29.  Full Article

Humanwell Healthcare Group unit passes FDA approval
Thursday, 23 Nov 2017 

Nov 23(Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS>:Says its 75 percent-owned unit received approval for its soft capsule named Dutasteride Capsule from U.S Food and Drug Administration .Says the unit will be able to sell Dutasteride Capsule in the United States after receiving the FDA approval.  Full Article

Humanwell Healthcare to sell bio-pharma firm for 350 mln yuan
Wednesday, 22 Nov 2017 

Nov 22 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS>:Says it plans to sell bio-pharma firm for 350 million yuan ($52.90 million).  Full Article

Humanwell Healthcare and unit to increase stake in Tianfeng Securities
Friday, 10 Nov 2017 

Nov 10 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS>:Says it and unit plan to acquire additional 2.18 percent stake in Tianfeng Securities for 305.1 million yuan ($45.97 million).  Full Article

Humanwell Healthcare Group completes issuance of 67.7 mln A shares in private placement
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS> ::Says it completed issuance of 67.7 million A shares of the company and raised 1.19 billion yuan in private placement .  Full Article

Humanwell Healthcare's 9-month net profit up 211.3 pct y/y
Monday, 30 Oct 2017 

Oct 30 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS>:Says 9-month net profit up 211.3 percent y/y.  Full Article

Humanwell Healthcare Group unit receives approval for drug clinical trial
Friday, 27 Oct 2017 

Oct 27(Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS>:Says unit Yichang Humanwell pharmaceutical Co Ltd received approval for drug clinical trial for a kind of injection M6G, from China Food and Drug Administration .  Full Article

Humanwell Healthcare Group unit receives FDA approval
Wednesday, 11 Oct 2017 

Oct 11 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS>:* Says its unit, PuraCap Pharmaceutical LLC, received approval for its Pioglitazone Tablet from U.S Food and Drug Administration .* Says its unit will be able to sell its Pioglitazone Tablet in the United States after receiving the FDA approval.  Full Article